Rep. Lisa C. McClain Purchases Shares of Baxter International Inc. (NYSE:BAX)

Key Points

• Representative Lisa C. McClain purchased shares of Baxter International Inc. (NYSE:BAX) for an amount between $1,001 and $15,000 on July 22nd, 2025.
• Baxter's recent earnings report showed a missed EPS estimate of $0.59, compared to the expected $0.60, with revenues of $2.81 billion for the quarter.
• The company has announced a quarterly dividend of $0.17 per share, which will be paid on October 1st, resulting in a yield of 2.8%.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Baxter International Inc. NYSE: BAX. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Baxter International stock on July 22nd. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
• Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
• Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
• Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
• Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Baxter International Stock Down 0.3%

NYSE:BAX traded down $0.0750 during trading hours on Wednesday, hitting $24.2550. The stock had a trading volume of 5,385,881 shares, compared to its average volume of 5,305,861. The company has a market cap of $12.46 billion, a PE ratio of -80.85, a price-to-earnings-growth ratio of 0.77 and a beta of 0.59. The business has a 50 day simple moving average of $27.88 and a two-hundred day simple moving average of $30.32. Baxter International Inc. has a 1-year low of $21.33 and a 1-year high of $40.49. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30.

Baxter International (NYSE:BAX - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.01). The firm had revenue of $2.81 billion during the quarter, compared to analysts' expectations of $2.82 billion. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. Baxter International's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.68 earnings per share. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. Analysts predict that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Friday, August 29th. Baxter International's dividend payout ratio is currently -226.67%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on BAX. Wells Fargo & Company lowered their target price on Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Evercore ISI reduced their price target on Baxter International from $44.00 to $42.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Stifel Nicolaus restated a "hold" rating and set a $25.00 price objective (down from $36.00) on shares of Baxter International in a report on Monday, August 4th. Wall Street Zen lowered Baxter International from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Finally, The Goldman Sachs Group cut Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 target price for the company. in a research note on Friday, August 1st. Three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $30.11.

Hedge Funds Weigh In On Baxter International

Several hedge funds and other institutional investors have recently modified their holdings of the company. Dodge & Cox boosted its stake in Baxter International by 1.3% during the 2nd quarter. Dodge & Cox now owns 52,121,620 shares of the medical instruments supplier's stock valued at $1,578,243,000 after purchasing an additional 662,695 shares during the period. Geode Capital Management LLC boosted its stake in Baxter International by 2.6% during the 2nd quarter. Geode Capital Management LLC now owns 12,882,960 shares of the medical instruments supplier's stock valued at $388,416,000 after purchasing an additional 326,652 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Baxter International by 1.3% during the second quarter. Ameriprise Financial Inc. now owns 7,638,629 shares of the medical instruments supplier's stock valued at $231,304,000 after buying an additional 97,687 shares in the last quarter. Sound Shore Management Inc. CT grew its stake in shares of Baxter International by 13.7% in the 1st quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier's stock worth $96,731,000 after purchasing an additional 341,321 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its position in Baxter International by 13.4% in the second quarter. Russell Investments Group Ltd. now owns 1,900,828 shares of the medical instruments supplier's stock worth $57,568,000 after buying an additional 224,804 shares during the last quarter. Institutional investors and hedge funds own 90.19% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.